Mumbai, India, 400080
This compound is an intermediate, or precursor, in the multi-step chemical synthesis of acalabrutinib. Acalabrutinib is a kinase inhibitor used to treat mantle cell lymphoma and chronic lymphocytic leukemia. CAS No: -850568-25-1
| Melting Point: | 124–128°C |
| Synonyms:- | (4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid, 4-(Pyridin-2-yl-aminocarbonyl)benzeneboronic acid, [4- [(Pyridin-2-yl)carbamoyl]phenyl]boronic acid, 4-(2-pyridylcarbamoyl)benzeneboronic acid, N-2- Pyridinyl 4-boronobenzamide |
| Packing :- | Powder form :- 25 Kg in HEDP bag with 2 liners (5 layer protected bag) |
| Solubility: | Slightly soluble in water (1.8 g/L at 25°C) |
| Density: | 1.33 g/cm³ |
| Molecular Weight: | 242.042 g/mol |
| Molecular Formula: | C₁₂H₁₁BN₂O₃ |